SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-007223
Filing Date
2024-02-20
Accepted
2024-02-20 16:15:41
Documents
18
Period of Report
2024-02-14
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41245
2 ex16-1.htm EX-16.1 3993
3 ex16-1_001.jpg GRAPHIC 6038
4 ex16-1_004.jpg GRAPHIC 2210
5 ex16-1_003.jpg GRAPHIC 34673
  Complete submission text file 0001493152-24-007223.txt   286243

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE glsi-20240214.xsd EX-101.SCH 3054
7 XBRL LABEL FILE glsi-20240214_lab.xml EX-101.LAB 34916
8 XBRL PRESENTATION FILE glsi-20240214_pre.xml EX-101.PRE 22815
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3889
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 24653493
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)